Actively Recruiting
Omega-3, Autism Spectrum Disorder (ASD)
Led by China Medical University Hospital · Updated on 2026-01-26
50
Participants Needed
1
Research Sites
211 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
CONDITIONS
Official Title
Omega-3, Autism Spectrum Disorder (ASD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of autism spectrum disorder by a child and adolescent psychiatrist according to DSM5
- Age between 6 and 17 years at enrollment
- No changes in pharmacotherapy or non-pharmacotherapy treatments within the past 4 weeks
- Signed informed consent
You will not qualify if you...
- Other psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, or substance use disorder
- Physical disorders including thyroid dysfunction, cerebral palsy, or coagulation disorders
- Current use of omega-3 supplements or probiotics
- Allergy to omega-3
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University
Taichung, Taichung, Taiwan, 404
Actively Recruiting
Research Team
P
Pei-Chen Chang, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here